Patel, A. Et Al. 2016. Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.. Hepatology international , vol.10 , 139-46.

Patel, A., Yapali, S., & Lok, A., (2016). Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.. Hepatology international , vol.10, 139-46.

Patel, A, Suna YAPALI, And AS Lok. "Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.," Hepatology international , vol.10, 139-46, 2016

Patel, A Et Al. "Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.." Hepatology international , vol.10, pp.139-46, 2016

Patel, A. Yapali, S. And Lok, A. (2016) . "Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.." Hepatology international , vol.10, pp.139-46.

@article{article, author={A Patel Et Al. }, title={Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.}, journal={Hepatology international}, year=2016, pages={139-46} }